Genopathy
Gene-Disorder Association · Article
Gene
PPARG
Peroxisome Proliferator Activated Receptor Gamma
Manually curatedApproved treatment annotated
Association Review

In brief

The association between PPARG (Peroxisome Proliferator Activated Receptor Gamma) and Lipid Metabolism Disorder is reported, with clinical genetic testing available.

Sources 1
Clinical variants 0
Symptoms 0
Compounds 4
Trials 4of 48 via PPARG compounds
Publications 20
01
At a glance

Association overview

A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.

Request access
02
Provenance

Evidence and sources

1 source

Every contributing database and publication behind this association, with evidence type, strength, accessions and deep links.

Request access
03
PPARG

The gene

2 source summaries

A gene summary alongside the source descriptions it was distilled from.

Request access
04
Lipid Metabolism Disorder

The disorder

10 database identifiers

The disorder’s summary, prevalence, aliases and cross-reference identifiers (OMIM, Orphanet, MONDO, ICD-10, MedGen).

Request access
05
Interventions

Therapeutics

4 compounds & drugs

Gene-targeting drugs and associated compounds, with class, approval status, mechanism, indications and trials.

Request access
06
Human studies

Clinical trials

48 clinical trials

Clinical trials reached through the pair’s compounds, keeping disorder-targeting trials separate from other indications.

Request access
07
Literature

Reading

20 publications

Publications linking the gene and the disorder, with title, authors, journal, year and citation metrics.

Request access
08
Provenance

References & sources

13 references

Every source and publication cited across this dossier, as one numbered reference list.

Request access